Protein discovery could help solve prostate cancer drug resistance

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly-used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart